Form 4: HCA Healthcare Executive Jon M. Foster Reports Share Transactions
SEC Form 4 Filing
HCA Healthcare's EVP and COO, Jon M. Foster, reported multiple transactions involving company stock, including acquisitions, disposals, and transfers to trusts.
Summary
- Jon M. Foster, EVP and COO of HCA Healthcare, filed a Form 4 detailing changes in his beneficial ownership of company stock.
- The transactions include the transfer of 9,502 shares to a trust in exchange for assets of equal value at $352.74 per share.
- Foster also acquired and disposed of shares through various means, including gifts and the exercise of stock appreciation rights.
- These transactions involved both direct and indirect ownership through trusts and a spouse.
- The reported transactions occurred on November 14, 2024, and May 15, 2024.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment. It is a routine filing.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for executives of publicly traded companies. It provides transparency into the trading activities of key personnel.
Comparison to Industry Standards
- Form 4 filings are standard practice for executives at publicly traded companies like HCA Healthcare, similar to filings made by executives at other large healthcare providers such as Universal Health Services (UHS) and Tenet Healthcare (THC).
- The transactions reported are typical for executives who receive stock-based compensation and manage their personal portfolios, similar to what is seen at other large companies.
- The use of trusts for asset management is a common practice among high-net-worth individuals, including executives at companies like HCA.
Related Party Transactions
- Transactions involved trusts where the reporting person and their spouse are trustees.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are routine insider transactions.
- The filing provides transparency to shareholders regarding executive stock ownership.
Key Dates
| Date | Description |
|---|---|
| 02/15/2011 | Date of the Limited Power of Attorney for SEC Reporting Obligations. |
| 05/15/2024 | Date of initial stock transactions reported. |
| 11/14/2024 | Date of the majority of stock transactions reported. |
| 11/18/2024 | Date of signature on the Form 4 filing. |
| 01/31/2028 | Expiration date of the stock appreciation rights. |
Keywords
HCA Healthcare, Form 4, insider trading, stock transactions, beneficial ownership, stock appreciation rights, trusts, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.